SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Arlington Asset Investment Corp. – ‘10-Q’ for 6/30/19 – ‘EX-31.02’

On:  Friday, 8/9/19, at 1:52pm ET   ·   For:  6/30/19   ·   Accession #:  1564590-19-31158   ·   File #:  1-34374

Previous ‘10-Q’:  ‘10-Q’ on 5/3/19 for 3/31/19   ·   Next:  ‘10-Q’ on 11/8/19 for 9/30/19   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/19  Arlington Asset Investment Corp.  10-Q        6/30/19   65:13M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.13M 
 2: EX-31.01    Certification -- §302 - SOA'02                      HTML     28K 
 3: EX-31.02    Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.01    Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.02    Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Document And Entity Information                     HTML     65K 
13: R2          Consolidated Balance Sheets                         HTML    107K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     43K 
15: R4          Consolidated Statements of Comprehensive Income     HTML    106K 
                (Unaudited)                                                      
16: R5          Consolidated Statements of Changes in Equity        HTML     90K 
                (Unaudited)                                                      
17: R6          Consolidated Statements of Changes in Equity        HTML     33K 
                (Parenthetical)                                                  
18: R7          Consolidated Statements of Cash Flows (Unaudited)   HTML     98K 
19: R8          Organization and Basis of Presentation              HTML     30K 
20: R9          Summary of Significant Accounting Policies          HTML     50K 
21: R10         Investments in Agency MBS                           HTML     61K 
22: R11         Borrowings                                          HTML    131K 
23: R12         Derivative Instruments                              HTML    604K 
24: R13         Offsetting of Financial Assets and Liabilities      HTML    305K 
25: R14         Fair Value Measurements                             HTML    234K 
26: R15         Income Taxes                                        HTML     34K 
27: R16         Earnings (Loss) Per Share                           HTML     69K 
28: R17         Stockholders' Equity                                HTML    104K 
29: R18         Summary of Significant Accounting Policies          HTML     88K 
                (Policies)                                                       
30: R19         Investments in Agency MBS (Tables)                  HTML     56K 
31: R20         Borrowings (Tables)                                 HTML    133K 
32: R21         Derivative Instruments (Tables)                     HTML    600K 
33: R22         Offsetting of Financial Assets and Liabilities      HTML    303K 
                (Tables)                                                         
34: R23         Fair Value Measurements (Tables)                    HTML    222K 
35: R24         Earnings (Loss) Per Share (Tables)                  HTML     68K 
36: R25         Stockholders' Equity (Tables)                       HTML     83K 
37: R26         Organization and Basis of Presentation -            HTML     24K 
                Additional Information (Details)                                 
38: R27         Summary of Significant Accounting Policies -        HTML     22K 
                Additional Information (Details)                                 
39: R28         Investments in Agency MBS - Additional Information  HTML     23K 
                (Details)                                                        
40: R29         Investments in Agency MBS - Additional Information  HTML     30K 
                About Gains and Losses Recognized with Respect to                
                Investments in MBS classified as trading                         
                securities (Details)                                             
41: R30         Borrowings - Outstanding Repurchase Agreement       HTML     37K 
                Borrowings (Details)                                             
42: R31         Borrowings - Outstanding Repurchase Agreement       HTML     24K 
                Borrowings (Parenthetical) (Details)                             
43: R32         Borrowings - Information Regarding Outstanding      HTML     25K 
                Repurchase Agreement Borrowings During the Period                
                (Details)                                                        
44: R33         Borrowings - Additional Information (Details)       HTML     26K 
45: R34         Borrowings - Long-term Unsecured Debt Instruments   HTML     54K 
                (Details)                                                        
46: R35         Derivative Instruments - Fair Value of Derivative   HTML     32K 
                Instruments (Details)                                            
47: R36         Derivative Instruments - Interest Rate Swap         HTML     52K 
                Agreements (Details)                                             
48: R37         Derivative Instruments - Additional Information     HTML     37K 
                (Details)                                                        
49: R38         Derivative Instruments - TBA Commitments (Details)  HTML     73K 
50: R39         Derivative Instruments - Derivative Gains and       HTML     47K 
                Losses Recognized Within the Periods (Details)                   
51: R40         Derivative Instruments - Volume of Activity, in     HTML     51K 
                terms of Notional Amount, Related to Derivative                  
                Instruments (Details)                                            
52: R41         Derivative Instruments - Cash Collateral Posted     HTML     26K 
                and Received in Respect of Derivative and Other                  
                Financial Instruments (Details)                                  
53: R42         Offsetting of Financial Assets and Liabilities -    HTML     96K 
                Derivative Instruments and Short-term Borrowing                  
                Arrangements, including those Subject to Master                  
                Netting or Similar Arrangements (Details)                        
54: R43         Fair Value Measurements - Additional Information    HTML     46K 
                (Details)                                                        
55: R44         Fair Value Measurements - Financial Instruments     HTML     63K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
56: R45         Fair Value Measurements - Change in Fair Value of   HTML     35K 
                Level 3 Investments that are Measured at Fair                    
                Value on Recurring Basis (Details)                               
57: R46         Income Taxes - Additional Information (Details)     HTML     73K 
58: R47         Earnings (Loss) Per Share - Computations of Basic   HTML     40K 
                and Diluted Earnings (Loss) Per Share (Details)                  
59: R48         Earnings (Loss) Per Share - Additional Information  HTML     26K 
                (Details)                                                        
60: R49         Stockholders' Equity - Additional Information       HTML    178K 
                (Details)                                                        
61: R50         Stockholders' Equity - Dividends Declared and Paid  HTML     33K 
                (Details)                                                        
62: R51         Stockholders' Equity - Issuances of Stock under     HTML     44K 
                Equity Distribution Agreements (Details)                         
64: XML         IDEA XML File -- Filing Summary                      XML    118K 
63: EXCEL       IDEA Workbook of Financial Reports                  XLSX     80K 
 6: EX-101.INS  XBRL Instance -- ai-20190630                         XML   4.10M 
 8: EX-101.CAL  XBRL Calculations -- ai-20190630_cal                 XML    133K 
 9: EX-101.DEF  XBRL Definitions -- ai-20190630_def                  XML    714K 
10: EX-101.LAB  XBRL Labels -- ai-20190630_lab                       XML   1.08M 
11: EX-101.PRE  XBRL Presentations -- ai-20190630_pre                XML    888K 
 7: EX-101.SCH  XBRL Schema -- ai-20190630                           XSD    172K 
65: ZIP         XBRL Zipped Folder -- 0001564590-19-031158-xbrl      Zip    182K 


‘EX-31.02’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

 

Exhibit 31.02

CERTIFICATION

I, Richard E. Konzmann, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 of Arlington Asset Investment Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 9, 2019

 

/s/ RICHARD E. KONZMANN

 

 

Richard E. Konzmann

Executive Vice President,

Chief Financial Officer and Treasurer

(Principal Financial Officer)

 

 


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/9/19None on these Dates
For Period end:6/30/19
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/08/21  Arlington Asset Investment Corp.  424B5                  1:719K                                   Donnelley … Solutions/FA
 7/06/21  Arlington Asset Investment Corp.  424B5                  1:724K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001564590-19-031158   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 11, 7:40:06.1am ET